CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FierceBiotech
Original article

{"a":[{"_":"Chai tees up Bristol Myers Squibb AI antibody discovery collab","$":{"href":"/medtech/chai-tees-bristol-myers-squibb-ai-antibody-discovery-collab-deal","hreflang":"en"}}]}

PartnershipPositive
AI Analysis

Summary

Chai Discovery, following a $400 million Series C funding round, has entered into an AI antibody discovery collaboration with Bristol Myers Squibb.

Outcome Details

AI antibody discovery collaboration

Importance:6/10
Sentiment:
0.60
AI drug discoveryPartnershipAntibody discoverySeries C funding
Related Companies

Read the original article

Published by FierceBiotech on August 20, 2026 9:59 AM

Read Original